Breaking News Instant updates and real-time market news.

A

Agilent

$53.20

-0.115 (-0.22%)

, ILMN

Illumina

$163.49

3.07 (1.91%)

16:07
03/20/17
03/20
16:07
03/20/17
16:07

Agilent appoints Raha to head corporate development

Agilent Technologies (A) announced that Samraat Raha has been named SVP of strategy and corporate development. "Raha will serve as strategic lead and advisor to the CEO and executive team in developing Agilent's overall growth strategy, including leading its mergers and acquisitions plans globally," the company noted. "Sam shares our vision of the marketplace and knows what it takes to drive new growth," commented CEO Mike McMullen. Raha joins Agilent from Illumina (ILMN), where he most recently served as vice president of global marketing.

A

Agilent

$53.20

-0.115 (-0.22%)

ILMN

Illumina

$163.49

3.07 (1.91%)

  • 28

    Mar

  • 01

    Apr

A Agilent
$53.20

-0.115 (-0.22%)

01/04/17
COWN
01/04/17
DOWNGRADE
Target $51
COWN
Market Perform
Agilent downgraded to Market Perform from Outperform at Cowen
Cowen analyst Doug Schenkel downgraded Agilent to Market Perform from Outperform based on valuation. Schenkel maintained his $51 price target on Agilent shares.
01/18/17
DBAB
01/18/17
INITIATION
Target $54
DBAB
Buy
Agilent initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Dan Leonard started coverage of the Life Science Tools and Diagnostics sector, noting that he is generally positive on sector fundamentals. As part of the coverage, he initiated Agilent with a Buy rating and $54 price target.
02/07/17
GSCO
02/07/17
NO CHANGE
GSCO
Conviction Buy
Agilent remains a top pick ahead of Q4 earnings at Goldman
Goldman analyst Isaac Ro said Conviction Buy rated Agilent remains a top pcik and thinks shares are poised for another solid earnings beat on February 14. Management guided to 2.2% Q4 organic growth, but Ro notes the China business alone can drive nearly 200bps of total corporate growth, and combined with new products and pricing, should be sufficient to drive upside to organic growth.
03/15/17
MSCO
03/15/17
UPGRADE
Target $62
MSCO
Overweight
Agilent upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Steve Beuchaw upgraded Agilent to Overweight and raised his price target for the shares to $62 from $55.
ILMN Illumina
$163.49

3.07 (1.91%)

02/27/17
EVER
02/27/17
UPGRADE
EVER
Buy
Illumina upgraded to Buy from Hold at Evercore ISI
Evercore ISI analyst Ross Muken to Buy with a $190 price target following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. He sees an expansion in the sequencing landscape given Nova's application flexibility and believes it addresses capacity utilization challenges. Muken's forecast is now above consensus and expects performance to accelerate into 2H revenue beats and a solid pathway into 2018.
02/27/17
02/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) upgraded to Buy from Neutral at B. Riley by analyst Jeff Van Sinderen, who said last week's footwear show and latest channel checks underscore the company's potential for growth. 2. Illumina (ILMN) upgraded to Buy from Hold at Evercore ISI by analyst Ross Muken following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. 3. Carnival (CCL) upgraded Buy from Hold by Argus analyst John Staszak, who now believes that "continued " improvement in demand for cruises will improve the company's earnings and margins. 4. Cempra (CEMP) upgraded to Buy at Roth Capital by analyst Michael Higgins after the company announced positive Phase 3 results in the first of two skin infection studies with Taksta, and ahead of bone data in 2017. The analyst also raised his price target on the shares to $8 from $2.50. 5. Unilever (UN) upgraded to Neutral from Underperform at BofA Merrill Lynch by analyst David Hayes, citing valuation and his belief that the strategic review could accelerate margin development targets over the next 4 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/17
LEER
03/20/17
UPGRADE
Target $195
LEER
Outperform
Illumina upgraded to Outperform from Market Perform at Leerink
Leerink analyst Puneet Souda upgraded Illumina to Outperform and raised his price target for the shares to $195 from $138. Survey data across high-productivity labs suggest earlier than expected NovaSeq upgrades in 2017 and 2018, Souda tells investors in a research note.
03/20/17
03/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BofA Merrill Lynch analyst Tal Liani upgraded FireEye (FEYE) to Buy saying the combination of low valuation and expectations, many new solutions, and recent sales leadership changes creates significant upside potential over the next two years. The analyst believes investors under-appreciate FireEye's quality of management, recovery strategy, and the quality of its technology and solutions. 2. Morgan Stanley upgraded Welltower (HCN) to Overweight from Equal Weight and raised its price target to $73 from $65, with analyst Vikram Malhotra calling the stock his preferred play on senior housing given its premium market position and a relatively younger portfolio. 3. Tiffany (TIF) upgraded to Outperform from Market Perform by William Blair analyst Dylan Carden, citing the recent stabilization of comps sales as well as upcoming easier comparisons. 4. Illumina (ILMN) upgraded to Outperform from Market Perform at Leerink by analyst Puneet Souda , who said survey data across high-productivity labs suggest earlier than expected NovaSeq upgrades in 2017 and 2018. 5. Wedbush analyst Nick Setyan upgraded Shake Shack (SHAK) to Neutral from Underperform, saying valuation is now more in line with long-term opportunities. Setyan believes same-store-sales growth headwinds and softer new unit volumes in 2017 are now well understood and raised Shake Shack's price target to $33 from $30. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FDS

FactSet

$185.76

3.5 (1.92%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Recommendations
FactSet analyst commentary  »

FactSet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOK

Evoke Pharma

$3.44

0.07 (2.08%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Hot Stocks
Evoke Pharma announces topline results from comparative exposure PK study »

Evoke Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
JPMorgan to hold a forum »

Japan FinTech Forum is…

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
Piper Jaffray to hold a field trip »

Brazilian Agricultural…

EFX

Equifax

$109.97

-0.54 (-0.49%)

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 14

    Dec

CX

Cemex

$7.96

-0.13 (-1.61%)

07:37
10/23/17
10/23
07:37
10/23/17
07:37
Upgrade
Cemex rating change  »

Cemex upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$56.32

0.32 (0.57%)

, MD

Mednax

07:36
10/23/17
10/23
07:36
10/23/17
07:36
Conference/Events
American Society of Anesthesiology to hold annual meeting »

Anesthesiology 2017…

ABT

Abbott

$56.32

0.32 (0.57%)

MD

Mednax

ABBV

AbbVie

$96.10

-0.38 (-0.39%)

BAX

Baxter

$63.59

0.12 (0.19%)

CAE

CAE

$17.43

0.01 (0.06%)

DDD

3D Systems

$12.00

0.53 (4.62%)

EM

Emdeon

XENE

Xenon Pharmaceuticals

$3.25

0.05 (1.56%)

TRVN

Trevena

$1.76

0.1 (6.02%)

SIEGY

Siemens

$68.33

-1.245 (-1.79%)

NOVA

NovaMed

NUVA

NuVasive

$55.05

0.48 (0.88%)

PFE

Pfizer

$36.42

0.18 (0.50%)

INFI

Infinity Pharmaceuticals

$2.28

-0.12 (-5.00%)

KRO

Kronos Worldwide

$26.17

0.35 (1.36%)

MNK

Mallinckrodt

$32.42

-0.4 (-1.22%)

HAE

Haemonetics

$45.66

0.55 (1.22%)

EW

Edwards Lifesciences

$113.08

1.05 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 07

    Dec

CMCSA

Comcast

$37.22

0.32 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Recommendations
Comcast analyst commentary  »

Comcast video losses do…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

ENTA

Enanta

$48.16

0.76 (1.60%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Enanta announces 'positive' Phase 1 a/b clinical results for EDP-305 »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VZ

Verizon

$49.53

0.32 (0.65%)

, UNP

Union Pacific

$112.99

0.98 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

VZ

Verizon

$49.53

0.32 (0.65%)

UNP

Union Pacific

$112.99

0.98 (0.87%)

S

Sprint

$6.93

-0.14 (-1.98%)

PYPL

PayPal

$70.97

3.72 (5.53%)

CTL

CenturyLink

$19.04

0.55 (2.97%)

NSC

Norfolk Southern

$132.75

2.51 (1.93%)

FEYE

FireEye

$16.81

-0.01 (-0.06%)

AMTD

TD Ameritrade

$48.27

0.88 (1.86%)

PRU

Prudential

$110.78

1.18 (1.08%)

AVP

Avon Products

$2.28

0.02 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 29

    Nov

  • 07

    Dec

  • 16

    May

MRK

Merck

$63.88

0.13 (0.20%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.88

0.13 (0.20%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

PFE

Pfizer

$36.42

0.18 (0.50%)

AGN

Allergan

$188.28

-0.99 (-0.52%)

ONCE

Spark Therapeutics

$81.87

1.08 (1.34%)

PODD

Insulet

$61.58

-0.39 (-0.63%)

ACHN

Achillion

$4.15

-0.01 (-0.24%)

SNY

Sanofi

$49.51

-0.51 (-1.02%)

ABEO

Abeona Therapeutics

$19.00

1.25 (7.04%)

JNJ

Johnson & Johnson

$142.40

0.36 (0.25%)

AZN

AstraZeneca

$34.62

-0.09 (-0.26%)

SHPG

Shire

$145.25

-2.57 (-1.74%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

BMY

Bristol-Myers

$64.42

-0.25 (-0.39%)

SCMP

Sucampo

$10.30

0.05 (0.49%)

PCRX

Pacira

$33.50

0.4 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

AAPL

Apple

$156.25

0.27 (0.17%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Recommendations
Apple analyst commentary  »

Apple supply/demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
T-Mobile raises low end of postpaid net custuomer adds view to 3.3M-3.6M »

T-Mobile says, "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
Kimberly-Clark says Q3 a 'challenging environment' »

Chairman and CEO Thomas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

BKS

Barnes & Noble

$7.35

0.15 (2.08%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
Barnes & Noble management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
T-Mobile sees FY branded postpaid phone ARPU 'generally stable' to FY16 »

T-Mobile continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

DCPH

Deciphera

$20.15

0.31 (1.56%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Earnings
Kimberly-Clark backs FY17 EPS view at low end of $6.20-$6.35 »

FY17 consensus $6.20. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ZKIN

ZK International Group

$8.23

0.07 (0.86%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
ZK International Group invited by Shenzhen Water Group »

ZK International Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Earnings
T-Mobile reports Q3 EPS 63c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

EGL

Engility

$33.41

-0.11 (-0.33%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Hot Stocks
Engility wins $14M contract from Defense Intelligence Agency »

Engility Holdings won a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 09

    Nov

  • 14

    Dec

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

DHI

D.R. Horton

$42.67

0.14 (0.33%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.